Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

Shares of Quantum BioPharma are surging in Monday morning trading. The stock is higher following a series of positive updates ...

Market volatility persists as investors focus on short-term earnings, overlooking systemic risks like tariffs, liquidity mismatches, and the dangers of efficiency over antifragility in the financial ...

From the overall spotted trades, 4 are puts, for a total amount of $989,596 and 36, calls, for a total amount of $4,160,511. Based on the trading activity, it appears that the significant investors ...

This is poised to be AI's worst single-session drop ever. The shares earlier fell to a two-year low of $14.70, and are now 53% lower in 2025. The selloff has pushed the equity's 14-Day Relative ...

Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...

Functional coffee is booming, with global sales hitting $4.48bn and growing fast. Consumers want more than caffeine - they’re seeking energy, immunity, and cognitive boosts from adaptogens, nootropics ...

Bullish on Monday said it now plans to sell 30 million shares at between $32 and $33 apiece in the IPO, up from prior plans to offer 20.3 million shares at between $28 and $31 each.

Reliance Consumer Products, in collaboration with Ceylon Cold Stores, introduces the iconic Campa Beverages brand in Sri ...

Guess how many of those alternative funds still exist? 341. The other 1,000 or so have been liquidated or merged away, a 75% ...

BTC’s implied volatility jumps from 33 to 37 after hitting multi-year lows, raising the odds of a bigger market move ahead.